Title of article :
The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles
Author/Authors :
Rahimi, Zohreh Medical Biology Research Center - Kermanshah University of Medical Sciences , Chamaie-Nejad, Foroogh Department of Clinical Biochemistry - Medical School - Kermanshah University of Medical Sciences , Saeidi, Shohreh Department of Clinical Biochemistry - Medical School - Kermanshah University of Medical Sciences , Rahimi, Ziba Medical Biology Research Center - Kermanshah University of Medical Sciences , Ebrahimi, Ali Department of Dermatology - Kermanshah University of Medical Sciences , Shakiba, Ebrahim Department of Clinical Biochemistry - Medical School - Kermanshah University of Medical Sciences , Vaisi-Raygani, Asad Department of Clinical Biochemistry - Medical School - Kermanshah University of Medical Sciences
Abstract :
Background: The aim of present study was to clarify the role of the peroxisome proliferator-activated receptor (PPAR)
γ Pro12Ala and C161T polymorphisms in the pathogenesis of polycystic ovary syndrome (PCOS) and their influence
on lipid and lipoprotein profiles of patients.
Materials and Methods: The present cross-sectional study consisted of 50 women with PCOS, who referred to the
Kermanshah University of Medical Sciences Clinic between April and October 2015, and 233 unrelated age-matched
healthy women from the same region (West Iran). The PPARγ Pro12Ala and PPARγ C161T polymorphisms were genotyped
using the polymerase chain reaction-restriction fragment length polymorphism method. Fasting blood sugar
(FBS), serum triglycerides (TG), cholesterol, low density lipoprotein- cholesterol (LDL-C), high density lipoproteincholesterol
(HDL-C) and estradiol levels were measured.
Results: The serum level of estradiol was significantly lower in PCOS patients compared to healthy women. The PPARγ
Pro12Ala (CG) genotype increased the risk of PCOS 2.96-fold. The frequency of the PPARγ T allele (at C161T) was 21%
in patients and 17.2% in controls with no significant difference (P=0.52). In all studied individuals, the PPARγ CG genotype
was associated with significantly higher levels of TG. However, significantly lower levels of total cholesterol and
LDL-C were observed in PPARγ TT individuals compared with those with the CC genotype. Within the PCOS group, the
PPARγ CG genotype was significantly associated with lower levels of estradiol compared with the CC genotype. Also,
the CG genotype was significantly associated with higher levels of TG when compared with the CC genotype.
Conclusion: Our study shows that, unlike PPARγ C161T, PPARγ Pro12Ala is associated with the risk of PCOS. Also,
we found that the lipid and lipoprotein profiles significantly vary based on PPARγ Pro12Ala and C161T genotypes.
Keywords :
Estradiol , Polycystic Ovary Syndrome , Lipoprotein , Peroxisome Proliferator-Activated Receptor , Lipid
Journal title :
Astroparticle Physics